Goldstraw Peter, Crowley John, Chansky Kari, Giroux Dorothy J, Groome Patti A, Rami-Porta Ramon, Postmus Pieter E, Rusch Valerie, Sobin Leslie
Royal Brompton Hospital, Imperial College, London, United Kingdom.
J Thorac Oncol. 2007 Aug;2(8):706-14. doi: 10.1097/JTO.0b013e31812f3c1a.
The seventh edition of the TNM Classification of Malignant Tumors is due to be published early in 2009. In preparation for this, the International Association for the Study of Lung Cancer established its Lung Cancer Staging Project in 1998. The recommendations of this committee for changes to the T, N, and M descriptors have been published. This report contains the proposals for the new stage groupings.
Data were contributed from 46 sources in more than 19 countries. Adequate data were available on 67,725 cases of non-small cell lung cancer treated by all modalities of care between 1990 and 2000. The recommendations for changes to the T, N, and M descriptors were incorporated into TNM subsets. Candidate stage groupings were developed on a training subset and tested in a validation subset.
The suggestions include additional cutoffs for tumor size, with tumors >7 cm moving from T2 to T3; reassigning the category given to additional pulmonary nodules in some locations; and reclassifying pleural effusion as an M descriptor. In addition, it is suggested that T2b N0 M0 cases be moved from stage IB to stage IIA, T2a N1 M0 cases from stage IIB to stage IIA, and T4 N0-1 M0 cases from stage IIIB to stage IIIA.
Such changes, if accepted, will involve a reassessment of existing treatment algorithms. However, they are based on an intensive and validated analysis of the largest database to date. The proposed changes would improve the alignment of TNM stage with prognosis and, in certain subsets, with treatment.
《恶性肿瘤TNM分类》第七版定于2009年初出版。为此,国际肺癌研究协会于1998年设立了肺癌分期项目。该委员会关于T、N和M描述符变更的建议已经公布。本报告包含新分期分组的提议。
数据来自19个以上国家的46个来源。1990年至2000年间,有足够的数据用于分析67725例接受各种治疗方式的非小细胞肺癌病例。T、N和M描述符变更的建议被纳入TNM亚组。候选分期分组在一个训练亚组上制定,并在一个验证亚组中进行测试。
建议包括对肿瘤大小增加额外的临界值,肿瘤>7 cm从T2改为T3;重新划分某些部位额外肺结节的类别;以及将胸腔积液重新分类为M描述符。此外,建议将T2b N0 M0病例从IB期改为IIA期,T2a N1 M0病例从IIB期改为IIA期,T4 N0-1 M0病例从IIIB期改为IIIA期。
这些变更若被采纳,将需要重新评估现有的治疗方案。然而,它们是基于对迄今为止最大数据库的深入且经过验证的分析得出的。提议的变更将改善TNM分期与预后以及在某些亚组中与治疗的一致性。